Global Home Healthcare Market Opportunities and Forecast 2020-2027

1 Executive Summary 14

2 Market Introduction 17

• 2.1 Definition 18
• 2.2 Scope of the Study 18
• 2.3 List of Assumptions 19
• 2.4 Market Structure 19
• 2.5 Key Takeaways 20
• 2.6 Key Buying Criteria 20

3 Research Methodology 21

• 3.1 Primary Research Methodology 22
• 3.2 Secondary Research Methodology 23
• 3.3 Market Share Analysis 23
• 3.4 Trade Analysis 23
• 3.5 Market Pricing Approach 24

4 Market Impact Analysis 25

• 4.1 Porter’s Five Force Analysis 26
  • 4.1.1 Bargaining Power of Buyer 27
  • 4.1.2 Bargaining Power of Supplier 27
  • 4.1.3 Threat from substitute 27
  • 4.1.4 Threat from a New Entrant 27
  • 4.1.5 Intensity of Competitive Rivalry 28
• 4.2 Value Chain Analysis 28
  • 4.2.1 Device Manufacturers 28
  • 4.2.2 App Developers 28
  • 4.2.3 Network providers/ Mobile operators 29
  • 4.2.4 Healthcare providers and Pharmaceuticals 29
  • 4.2.5 Patients 29
• 4.3 Pricing Analysis 29
  • 4.3.1 Cost-effectiveness and patients’ convenience will drive the home healthcare market 29
• 4.4 Investment Opportunity Analysis 30
  • 4.4.1 Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions 30

5 Market Dynamics 31

• 5.1 Introduction 32
• 5.2 Drivers 33
  • 5.2.1 Growing geriatric population 33
  • 5.2.2 Rising treatment cost and hospital stay 34
  • 5.2.3 Technological advancements 35
• 5.3 Restraints 36
  • 5.3.1 Patients Safety Concerns 36
• 5.4 Opportunities 37
  • 5.4.1 Rising prevalence of Chronic Disorders 37
  • 5.4.2 Improvement in Reimbursement Scenario 38
• 5.5 Mega Trends 39
  • 5.5.1 Telemedicine 39
• 5.6 Macroeconomic Indicators 39
• 5.7 Technology Trends & Assessment 39

6 Global Home Healthcare Market by Product 40

• 6.1 Introduction 41
  • 6.1.1 Testing, Screening, & Monitoring Products 42
  • 6.1.2 Therapeutic Products 43

7 Global Home Healthcare Market by Services 44

• 7.1 Introduction 45
  • 7.1.1 Skilled Nursing Services 46
  • 7.1.2 Rehabilitation Therapy Services 46
  • 7.1.3 Unskilled Care Services 46
  • 7.1.4 Respiratory Therapy Services 47
  • 7.1.5 Infusion Therapy Services 47
  • 7.1.6 Pregnancy Care Services 48

8 Global Home Healthcare Market by Software 49

• 8.1 Introduction 50
  • 8.1.1 Clinical Management Systems 51
  • 8.1.2 Agency Software 51
  • 8.1.3 Telehealth Solution 51
  • 8.1.4 Hospice Solutions 52

9 Global Home Healthcare Market by Region 53

• 9.1 Introduction 54
• 9.2 Americas 55
  • 9.2.1 North America 59
    • 9.2.1.1 U.S. 61
    • 9.2.1.2 Canada 63
  • 9.2.2 South America 65
• 9.3 Europe 68
  • 9.3.1 Western Europe 72
    • 9.3.1.1 Germany 74
    • 9.3.1.2 France 77
    • 9.3.1.3 U.K. 79
    • 9.3.1.4 Italy 81
    • 9.3.1.5 Spain 83
    • 9.3.1.6 Rest of Western Europe 85
  • 9.3.2 Eastern Europe 87
• 9.4 Asia Pacific 90
  • 9.4.1 Japan 94
  • 9.4.2 China 96
  • 9.4.3 India 98
  • 9.4.4 Republic of Korea 100
  • 9.4.5 Australia 102
  • 9.4.6 Rest of Asia-Pacific 104
• 9.5 Middle East & Africa 107
  • 9.5.1 United Arab Emirates 110
  • 9.5.2 Saudi Arabia 112
  • 9.5.3 Oman 114
  • 9.5.4 Kuwait 116
  • 9.5.5 Qatar 118
  • 9.5.6 Rest of Middle East & Africa 120

10 Company Landscape 123

• 10.1 Competitive Landscape 124
• 10.2 Company Analysis 124
• 10.3 Company Market Share 124

11 Company Profiles 125

• 11.1 Abbott 126
  • 11.1.1 Financials 126
  • 11.1.2 Products 126
  • 11.1.3 Strategy 126
  • 11.1.4 Key Developments 126
• 11.2 GE Healthcare 127
  • 11.2.1 Financials 127
  • 11.2.2 Products 127
  • 11.2.3 Strategy 127
  • 11.2.4 Key Developments 127
• 11.3 Becton Dickinson 128
  • 11.3.1 Financials 128
  • 11.3.2 Products 128
  • 11.3.3 Strategy 128
  • 11.3.4 Key Developments 128
• 11.4 Omron Corporation 129
  • 11.4.1 Financials 129
  • 11.4.2 Products 129
  • 11.4.3 Strategy 129
  • 11.4.4 Key Developments 129
• 11.5 Apple 130
  • 11.5.1 Financials 130
  • 11.5.2 Products 130
  • 11.5.3 Strategy 130
  • 11.5.4 Key Developments 130
• 11.6 Medtronic PLC 131
  • 11.6.1 Financials 131
  • 11.6.2 Products 131
  • 11.6.3 Strategy 131
  • 11.6.4 Key Developments 131
• 11.7 Koninklijke Philips N.V. 132
  • 11.7.1 Financials 132
  • 11.7.2 Products 132
  • 11.7.3 Strategy 132
  • 11.7.4 Key Developments 132
• 11.8 LG Electronics 133
  • 11.8.1 Financials 133
  • 11.8.2 Products 133
  • 11.8.3 Strategy 133
  • 11.8.4 Key Developments 133
• 11.9 Fresenius SE & Co KGaA 134
  • 11.9.1 Financials 134
  • 11.9.2 Products 134
  • 11.9.3 Strategy 134
  • 11.9.4 Key Developments 134
• 11.10 McKesson Corporation 135
  • 11.10.1 Financials 135
  • 11.10.2 Products 135
  • 11.10.3 Strategy 135
  • 11.10.4 Key Developments 135
• 11.11 F. Hoffmann-La Roche AG 136
  • 11.11.1 Financials 136
  • 11.11.2 Products 136
  • 11.11.3 Strategy 136
  • 11.11.4 Key Developments 136
• 11.12 B. Braun Melsungen AG 137
  • 11.12.1 Financials 137
  • 11.12.2 Products 137
  • 11.12.3 Strategy 137
  • 11.12.4 Key Developments 137
• 11.13 3M 138
  • 11.13.1 Financials 138
  • 11.13.2 Products 138
  • 11.13.3 Strategy 138
  • 11.13.4 Key Developments 138
• 11.14 A&D Company 139
  • 11.14.1 Financials 139
  • 11.14.2 Products 139
  • 11.14.3 Strategy 139
  • 11.14.4 Key Developments 139
• 11.15 Kinnser Software 140
  • 11.15.1 Financials 140
  • 11.15.2 Products 140
  • 11.15.3 Strategy 140
  • 11.15.4 Key Developments 140

12 Conclusion 141

• 12.1 Key Findings 142
  • 12.1.1 From CEO’s View Point 142

13 Appendix 143

• 13.1 Discussion Blue Print 144